제놀루션

225220KOSDAQ기초 의약물질 제조업

56.5 / 100

Reference Date: 2026-06-10

Financial Score23.5 / 40

News Sentiment20.0 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Plunged 16.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Genolux operates in the molecular diagnostic equipment and RNAi research sectors, offering automated nucleic acid extraction devices and RNA synthesis services. The company has developed the world's first RNAi-based treatment for foulbrood disease in bees and obtained product approval, while expanding its RNAi-based agricultural pest control technologies.

Number of Employees

76people

Average Salary

53.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 27.714.0Point

PBR

0.42Industry Average 1.747.0Point

Half of industry avg (excellent)

ROE

-16.98Industry Average -6.033.5Point

2.8x industry avg (excellent)

Debt Ratio

0.44Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲2.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼11.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.6% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 1Negative 0Average Sentiment Score 80

Positive
제놀루션 자회사 비앙블바이오텍, 뷰티 브랜드 'KU:HAM' 출시
제놀루션 자회사 비앙블바이오텍의 신규 뷰티 브랜드 KU:HAM 출시로 인해 회사의 브랜드 확장 및 시장 경쟁력 강화가 기대됩니다.
Neutral
비앙블바이오텍, 신규 K-뷰티 브랜드 'KU:HAM(구함)' 출시
제놀루션 자회사 비앙블바이오텍의 신규 K뷰티 브랜드 출시 소식은 관련성은 있으나 직접적인 영향은 제한적임을 시사합니다.
Positive
제놀루션, 꿀벌 유충 사육 시스템 특허 등록
제놀루션의 꿀벌 유충 사육 시스템 특허 등록으로 연구 효율성 향상 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 1,489Won52-week high 2,59052-week low 1,489

1-month return0.0Point

1m -16.82% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최2026-05-27
Neutral분기보고서 (2026.03)2026-05-15